Macquarie Group
CERE

Macquarie Group’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Macquarie Group’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
2024
Q2 		$175K Buy
2022
Q4 		– Hold
2022
Q3 		– Sell
2022
Q2 		$18K Hold
2022
Q1 		$23 Hold
2021
Q4 		$22K Buy